Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues further extended

The Government has made The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024, which has the effect of extending the ban, which was due to expire.

The ban has been extended until 31 December 2024. The Secretary of State has expressed the intention to make the ban permanent, but can only do this by following a procedure set out in the Medicines Act 1968, including a formal consultation. The formal consultation has now ended and the extension to the ban will allow the Government time to consider the next steps using the responses to the consultation.

The ban was previously extended, in August, and our news article explaining this can be found here: Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues extended

Our previous news article, from May when the regulations were first introduced, can be found here: New legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues

More information regarding the ban can also be found on our webpage: Gonadotrophin Releasing Hormone (GnRH) Prescription Regulations